CIFoundry
Back to Catalog
Revenue Cycle & Prior AuthPrior authorizationPlatform
Alaffia

Covers: prior authorization, payment integrity, appeals

Last reviewed Nov 9, 2026 against the sources listed on this page · How we review

At a glance

Alaffia is a claims lifecycle platform for health plans that uses AI agents and clinician review to support prior authorization, payment integrity, and appeals workflows.

FDA:
Not on record
Epic:
Not on record
Named users:
Not on record
Published study:
Not on record

Description

Alaffia is a claims lifecycle platform for health plans that uses AI agents and clinician review to support prior authorization, payment integrity, and appeals workflows. It is used by payer teams that want help reviewing clinical records, validating claims, and outsourcing parts of claims operations.

Claims ReviewPrior AuthorizationPayment IntegrityAppeals

Quick answers

Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review

Does Alaffia have SOC 2 or HITRUST?
On record: SOC 2 Type II; HITRUST (level not stated). Ask the vendor for the current status and expected date.Vendor page, checked Nov 10, 2026
Does Alaffia use patient data to train its AI?
The vendor's own published materials say: Not used to train external models; the platform learns from the customer's own workflows and data. Make sure your contract says the same.Vendor page, checked Nov 10, 2026
What are alternatives to Alaffia?
We list 14 other tools of the same type (Prior authorization). Shown here: 5, those with more on the public record first, then A–Z. Compare them on the same questions.Availity Intelligent Utilization ManagementDevelop HealthForusFoundation Health Clinical ConnectorGenzeon PlatformsSee all 15

Security & contracting

From the vendor's published materials

Found by our team on the vendor's own pages, checked Nov 10, 2026. What the vendor states publicly, not an audit.

SOC 2
SOC 2 Type IIsource
HITRUST
HITRUST (level not stated)source
Customer data and model training
Not used to train external models; the platform learns from the customer's own workflows and datasource

The maker has not reported these details yet. Ask the vendor directly during evaluation.

Workflow stage
Not reported
Integrations
Not reported
Data inputs
Not reported
Deployment
Not reported
Signs a BAA
Not reported
SOC 2 report
Not reported
HITRUST
Not reported
Evidence type
Not assessed

Details below the boxes are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.

Who's using this

Organizations named in public announcements or by the developer. Inclusion is not an endorsement.

No public deployments found yet. Using this tool? The maker can claim the listing to add customers.

Get weekly updates for Revenue Cycle & Prior Auth

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

Sources

This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.

Website
History (4)Show

Dated events on this listing's public record, newest first.

  1. Nov 10, 2026

    Vendor fact recorded from the vendor's own page: SOC 2source

  2. Nov 10, 2026

    Vendor fact recorded from the vendor's own page: HITRUSTsource

  3. Nov 10, 2026

    Vendor fact recorded from the vendor's own page: Customer data and model trainingsource

  4. Nov 9, 2026

    Added to CIFoundry

Developer

Alaffia

Evaluating this tool?

Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.

Prepare evaluation packet

Checklist for your role: Admin · Physician · IT · Compliance

Compare similar tools →

Own this tool?

Claim this listing to update its details and connect with your audience.